Once-daily liraglutide vs lixisenatide as add-on to metformin in type 2 diabetes: a 26-week randomised controlled clinical trial

Nauck M.; Rizzo M.; Valdis Pīrāgs; Bosch-Traberg H.; Madsen J.; Cariou B.

Once-daily liraglutide vs lixisenatide as add-on to metformin in type 2 diabetes: a 26-week randomised controlled clinical trial

Nauck M.
, Rizzo M.
, Valdis Pīrāgs
, Bosch-Traberg H.
, Madsen J.
, Cariou B.

Research output: Contribution to journal › Meeting abstract › peer-review

Original language	English
Journal	Diabetologia
Volume	58
Publication status	Published - 2015
Event	51st Annual Meeting of the European Association for the Study of Diabetes (EASD), Stockholm, Sweden, Sept. 14-18, 2015 - Stokholma, Sweden Duration: 14 Sept 2015 → 18 Sept 2015

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

OECD Field of Science

3. Medical and Health Sciences

Cite this

@article{76dffd08a16c43a38a0c57891da6bdce,

title = "Once-daily liraglutide vs lixisenatide as add-on to metformin in type 2 diabetes: a 26-week randomised controlled clinical trial",

author = "Nauck M. and Rizzo M. and Valdis Pīrāgs and Bosch-Traberg H. and Madsen J. and Cariou B.",

year = "2015",

language = "English",

volume = "58",

journal = "Diabetologia",

issn = "0012-186X",

publisher = "Springer Science and Business Media Deutschland GmbH",

note = "51st Annual Meeting of the European Association for the Study of Diabetes (EASD), Stockholm, Sweden, Sept. 14-18, 2015, EASD ; Conference date: 14-09-2015 Through 18-09-2015",

}

TY - JOUR

T1 - Once-daily liraglutide vs lixisenatide as add-on to metformin in type 2 diabetes: a 26-week randomised controlled clinical trial

AU - M., Nauck

AU - M., Rizzo

AU - Pīrāgs, Valdis

AU - H., Bosch-Traberg

AU - J., Madsen

AU - B., Cariou

PY - 2015

Y1 - 2015

UR - http://link.springer.com/article/10.1007/s00125-015-3687-4

M3 - Meeting abstract

SN - 0012-186X

VL - 58

JO - Diabetologia

JF - Diabetologia

T2 - 51st Annual Meeting of the European Association for the Study of Diabetes (EASD), Stockholm, Sweden, Sept. 14-18, 2015

Y2 - 14 September 2015 through 18 September 2015

ER -

Once-daily liraglutide vs lixisenatide as add-on to metformin in type 2 diabetes: a 26-week randomised controlled clinical trial

UN SDGs

OECD Field of Science

Other files and links

Cite this